Lec 12- Atherosclerosis and its consequences Flashcards

1
Q

Terminology

A
  • Arteriosclerosis- hardening (sclerosis) or arteries. Medial hypertrophy- age and hypertension. Symmetrical and uniform
  • Atherosclerosis-related to hyperlipidaemia. Fatty fibrous plaques (atheromas) laid down on the inner surface of vessels (intima). Focal changes
  • Thrombosis- consequences of atherosclerosis. thrombus (clot) formed on inner surface of the vessel. May shed of small particles- thromboemboli, can occlude vessels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Atherosclerosis

A
  • A focal disease of large arteries (may also be found in atria). High pressure
  • Doesn’t occur naturally in animals
  • Plaques occur at sites of haemodynamic stress- increased endothelial cells turnover e.g. carotid bifurcation, coronaries, mesenteric, renal, aorta, iliac
  • Endothelial damage is initiating event
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Non-modifiable risk factor for atherosclerosis

A
  • Family history of IHD or hyperlipidaemia
  • Advanced age
  • Male sex (and female post-menopause)
  • Ethnic group
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Modifiable risk factors for atherosclerosis

A
  • Hyperlipidaemia (dyslipidaemia LDL/HDL)
  • Cigarette smoking
  • Hypertension
  • Obesity (waist to hip ratio)
  • Diabetes mellitus
  • Physical inactivity or sedentary lifestyle
  • Stress (psychosocial factors)
  • Diet poor in fruit and fresh vegetables
  • Account for 80% of the elevated risk: INTERHEART 2004
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Theories of atherosclerosis

A
  • Lipid Theory- High levels of blood cholesterol(LDC) injure endothelium + allow accumulation and local inflammation
  • Inflammation Theory- Local inflammatory reaction possibly through local injury, through infection (chlamydial or H.pylori), attracts macrophages
  • Inflammation- results from both pathways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Initiating events in atherogenesis (adhesion of monocytes and leucocytes to endothelial cell surface)

A
  • Earliest detectable evidence of pathophysiology is endothelial dysfunction Caused by:
  • Hypercholesterolaemia- particularly oxidised LDL-c
  • Cigarette smoking
  • Hypertension
  • Diabetes (partially due to lipid changes)
  • Infectious organism
  • Elevated level of NA and adrenaline

-Associated with reduced PgI2 and NO biosynthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lipid link to atherosclerosis

A
  • Atheroma risk directly linked to total plasma ChE
  • There is a link to dietary ChE but 75% of plasma from liver
  • LDL and VLDL carry ChE to tissues and HDL away to liver
  • LDL/HDL is diagnostic factor for risk but coronary risk correlates best with TOTL ChE/HDL ratio
  • Triglycerides are not significant factor in risk
  • Low intake of saturated fats and ChE reduce risk but don’t remove it
  • Lipid-lowering agent reduce risk of end events and give some regression of atherosclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does atherosclerosis develop

A

1) accumulation of modified lipid
2) endothelial cell activation
3) inflammatory cell migration
4) inflammation cell activation
5) smooth muscle cell recruitment
6) proliferation and matrix synthesis
7) fibrous cap formation
8) plaque erosion
9) platelet erosion
10) thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endothelial phase

A
  • Lipids become oxidised (initially in the circulation later in the intima)
  • Injury to endothelium causing the release of adhesion factors (VCAM-1). Attracts monocytes- activation and adherence
  • Endothelial cells bind LDL with endothelial transport of lipids (LDL-c) into the intima
  • Injured cells and monocytes generate free radicals and there is lipid peroxidation
  • Disruption of normal LDL receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Spreading damage

A
  • Macrophage engulf oxidised lipids and become lipid saturated foam cells
  • Macrophages move from bloodstream into the endothelial layer-large part of the atheroma mass
  • Cytokines from endothelial cells, macrophages and platelets cause smooth muscle proliferation and deposition of connective material
  • The fibrous material becomes a dense fibrous cap of connective materials
  • Underneath there is a much looser combination of lipids and necrotic cell debris and cholesterol crystals. Ca2+ build = sclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Plaque formation- The Fibro-lipid (fibro-fatty) plaque

A

The Fibro-lipid (fibro-fatty) plaque

  • An accumulation of lipid-laden cells in the tunica intima
  • Typically without narrowing the lumen
  • Fibrous cap covering the atheromatous core of the plaque
  • A core lipid-laden cells (macrophages and smooth muscle cells) with elevated tissue cholesterol and cholesterol ester content, fibrin, collagen, elastin, debris and proteoglycans
  • In advanced plaques, the central core of the plaque usually contains extracellular cholesterol deposits (dead cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

plaque formation- fibrous plaque

A
  • Is also localized within the wall of the artery resulting in thickening and expansion of the wall
  • The fibrous plaque contains collagen fibres (eosinophilic), precipitates of calcium and rarely, lipid-laden cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Early atheroma

A
  • Damage to endothelial (exacerbated by htn)
  • Insudation of cholesterol
  • Formation of foam cells
  • Cholesterol esters deposited in intima
  • Leads to fatty streaks or dots. Observed in children wide distribution- reversible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Advanced (fibrous) plaque 20yrs old

A
  • Pro-inflammatory cytokines cause VSM migration from the media to the intima. Synthesis of collagen and elastin producing fibrous cap
  • Variable amounts of lipid may be present
  • As the plaque enlarges, the base may start to become necrotic
  • No symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Progression of atheroma: advanced to complicated 20-30 yrs

A
  • The fibrous cap may slowly enlarge or may rupture
  • Rupture of plaque cap leads to thrombosis: rupture is likely is the base is necrotic, if there are large deposits of cholesterol. or high numbers of inflammatory cells present)
  • After fibrin clot has formed, this may be incorporated into a new (larger) plaque and a new connective tissue cap is formed: the plaque may progress suddenly in stages
  • Symptoms: non or minor due to minor embolisms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Further progression of plaques

A

-Gradual growth or further episodes of mural thrombosis causes stepwise progression of plaques which can have layered appearance: 70% of plaques show evidence of cap rupture with no evidence of clinical evidence; High flow rates may predispose to plaque rupture but also may prevent the formation of large thrombi

17
Q

Clinical horizon 40-60 years

A
  • When the lumen of major arteries becomes narrowed by greater then 75%
  • Symptoms: angina; intermittent claudication (iliac arteries or abdominal aorta); dizzy spells (carotid arteries); plaque disruption cause embolism at embolism at sites distal to the lesion
  • Symptoms: AMI: arrhythmias; CVA: peripheral ischaemia
  • Symptoms generally less severe than with large vessel occlusion
  • Those plaques where the cap has a high ratio of inflammatory cells to smooth muscle cells are most prone to rupture
18
Q

Clinical horizon continued

A
  • Plaque rupture and thrombosis may completely occlude lumen
  • Symptoms: AMI: CVA; sudden ischemic pain
  • This can occur even with no prior angiographically demonstrable reduction in lumen diameter. Plaque composition is more important than plaque size in determining stability
19
Q

An aneurysm

A
  • An aneurysm is a localised widening (dilation) of an artery, vein or heart
  • From the Greek meaning widening
  • In the area of an aneurysm, there is a typically a bulge and the wall is weakened and may rupture
  • A fusiform aneurysm is shaped like a spindle
  • Saccular is a sac-like aneurysm
  • A dissecting aneurysm- where the wall of an artery rips longitudinally. Due to bleeding into the weakened wall splits. A dissecting aneurysm tend to affect the thoracic aorta
20
Q

Peripheral arterial disease (occlusive)

A

Due to atherosclerosis (most common)
-Usually preferentially affects the lower limbs, but may also affect the upper limbs, particularly in cigarette smoking
- Symptoms: intermittent claudication; cold; pain; gangrene
-Pronounced colour changes: gangrene or sudden pain often indicate arterial occlusion due to thrombosis or embolism
Due to infection (rare): TB; syphilis
Due to structural abnormalities- arteritis
Cystic degeneration (rare tumours of media)

21
Q

Diagnosis and monitoring of peripheral arterial disease

A
  • Diagnosis: documentation of symptoms, inspection of limbs, assessment of pulses, Doppler for ankle-brachial pulse index (ABPI), angiogram
  • Monitor: Symptoms and response to exercise, physical look of limbs, APBI
22
Q

PVD (peripheral vascular disease): vasospastic

A

Raynaud’s disease (dead fingers)
-intermittent attacks of pallor or cyanosis usually on exposure to cold
-Bilateral or symmetrical (hands and feet)
-No organic disease- vasospasm
-Need to rule out autoimmune cause
Raynaud’s syndrome (similar symptoms but maybe 2ndary to organic disease of the arteries)
Acrocyanosis- persistent pallor and cyanosis (normal temp)
-Bilateral or symmetrical (hands and feet)
-Often accompanied by sweating
Erythromelalgia: (rare) pain; redness and heat- relieved by cooling and elevating the affected limb (or aspirin)

23
Q

steal in PVD

A
  • Ischemic areas may be maximally vasodilated due to local metabolic changes
  • Increased demands to hyperaemic areas (e.g. as result of exercise) may reduce flow to the ischaemic zone (steal). After exercise the O2 debt will be repaid 1st to those areas proximal to the stenosis
  • Vasodilators will preferentially dilate hyperaemic areas causing steal
24
Q

Treatment of PVD

A

Treat any conditions that increase CV risk
-HTN: aim for best control possible
-Diabetes: optimum diabetic control
-reduced risk of intravascular clotting- low dose aspirin (75mg)
-Reduce lipid intakes- statins are the drugs of choice. Aim total ChE <4mmol/L and LDL <2mmol/L
Advice to stop smoking- direct endothelial damage, carboxyHb, increased fibrinogen levels, peripheral vasoconstriction
Exercise and optimum diet. increases collaterals

25
Q

Drugs in occlusive PVD

A
  • Supervised exercise program
  • Aviod drugs which can exacerbate the condition (e.g. B-blockers)
  • Any anaemia should be correlated
  • Improved endothelial function
  • Peripheral vasodilators- theoretically beneficial. BUT steal is a big issue
  • Naftidrofuryl can help symptoms of intermittent claudication and improve walking distance in moderate disease and may be tried (NICE)
  • Other vasodilators no evidence of benefits
26
Q

Vasodilators in vasospastic PVD

A
  • Often more effective than in occlusive disease
  • Calcium entry blockers e.g. nifedipine may be more beneficial
  • Naftidrofuryl oxalate (5-HT inhibitor; praxiline-Merck)
  • Inositol Nicotinate- nicotinic acid derivatives.
  • Avoid exposure to control- probably most effect approach
  • Stop smoking
27
Q

Secondary prevention of CVS disease

A
  • Smoking cessation
  • Diet, weight management and exercise
  • Lipid modification and statin therapy, NICE guideline (aim total ChE <4mmol/L
  • The prevention, diagnosis and management of diabetes
  • The prevention, diagnosis and management of high blood pressure
  • Antiplatelet therapy
28
Q

Surgery in PVD

A
  • Balloon angioplasty

- Bypass Graft